About: Severe Acute Respiratory Syndrome (SARS): The Pharmacist's Role

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Severe Acute Respiratory Syndrome (SARS): The Pharmacist's Role Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Severe Acute Respiratory Syndrome (SARS): The Pharmacist's Role
Creator	Chant, Clarence Chin, Thomas Tanzini, Rosemary Wells, Janice
Source	Medline; PMC
abstract	Objectives. After two outbreaks of severe acute respiratory syndrome (SARS) occurred in Toronto, Ontario, Canada, from March–June 2003, we reviewed the unexpected role and responsibilities of pharmacists during these two crises, and present strategies for better crisis preparedness. Methods and Results. Pharmacists were actively involved in battling the SARS crises. After conducting extensive literature searches and evaluations, pharmacists prepared administration and dosing guidelines for the two investigational drugs, ribavirin and interferon alfacon‐1, that were being used to treat the syndrome. They provided direct patient care under modified conditions. They revised drug distribution procedures and developed new ones to meet more stringent infection‐control standards. Collaborative teamwork with key stakeholders was important in accomplishing tasks in an efficient and timely manner. Regular communication with health care staff took place internally and externally. Education and updated information for pharmacists was crucial. Conclusion. Pharmacists can play a vital role during crises in the areas of drug distribution, drug information, and direct patient care. Collaborative teamwork and close communication are keys to success. Pharmacists must be proactive and take a leadership role in assuming pharmacy‐related responsibilities. By evaluating what worked and what didn't, pharmacists can develop procedures for future crises requiring pharmacy support.
has issue date	2012-01-16(xsd:dateTime)
bibo:doi	10.1592/phco.24.8.705.36063
bibo:pmid	15222659
has license	no-cc
sha1sum (hex)	d2940b9d521b020e01f3ac9beab3d62286266b1a
schema:url	https://doi.org/10.1592/phco.24.8.705.36063
resource representing a document's title	Severe Acute Respiratory Syndrome (SARS): The Pharmacist's Role
has PubMed Central identifier	PMC7167812
has PubMed identifier	15222659
schema:publication	Pharmacotherapy
resource representing a document's body	covid:d2940b9d521b020e01f3ac9beab3d62286266b1a#body_text
is schema:about of	named entity 'health care' named entity 'communication' named entity 'Severe Acute Respiratory Syndrome (SARS)' named entity 'TIMELY' named entity 'PREPAREDNESS' named entity 'CARE STAFF' named entity 'THESE' named entity 'COLLABORATIVE' named entity 'IMPORTANT' named entity 'METHODS' named entity 'PATIENT CARE' named entity 'prepared' named entity 'pharmacists' named entity 'conditions' named entity 'areas' named entity 'responsibilities' named entity 'After' named entity '2003' named entity 'timely' named entity 'Pharmacists' named entity 'crises' named entity 'communication' named entity 'Role' named entity 'interferon alfacon-1' named entity 'Ontario' named entity 'patient care' named entity 'health care' named entity 'pharmacy' named entity 'updated' named entity 'comorbid conditions' named entity 'acute response' named entity 'cardiac arrest' named entity 'SARS' named entity 'pharmacy' named entity 'SARS' named entity 'plastic container' named entity 'pharmacist' named entity 'patient care' named entity 'e-mail' named entity 'SARS' named entity 'infection-control' named entity 'SARS' named entity 'flu-like illness' named entity 'SARS' named entity 'infectious disease' named entity 'pharmacy' named entity 'community-acquired pneumonia' named entity 'pharmacy' named entity 'renal impairment' named entity 'ribavirin' named entity 'broad-spectrum' named entity 'pharmacist' named entity 'respiratory care' named entity 'pharmacy' named entity 'toxicity' named entity 'pharmacy technician' named entity 'Infection control' named entity 'SARS' named entity 'SARS' named entity 'face shield' named entity 'decontamination' named entity 'SARS' named entity 'health care' named entity 'cytokine' named entity 'greater Toronto area' named entity 'goggles' named entity 'pharmacist' named entity 'patient care' named entity 'biohazard' named entity 'drug delivery' named entity 'inventory control' named entity 'evidence-based' named entity 'pharmacy' named entity 'infection-control' named entity 'public health emergency' named entity 'unused drug' named entity 'patient assessment' named entity 'SARS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software